| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Ke Wang CEO | XSHE Exchange | CNE100001070 ISIN |
| China Country | 979 Employees | 29 May 2026 Last Dividend | 31 May 2016 Last Split | 18 Feb 2011 IPO Date |
Changzhou Qianhong Biopharma CO., LTD is a prominent pharmaceutical company based in Changzhou, China. Established in 1971, the company has specialized in the manufacture and distribution of a wide range of pharmaceutical products, specifically focusing on polysaccharide and protease drugs. With a focus on high-quality standards, Changzhou Qianhong Biopharma has been serving the healthcare industry in China by providing an extensive portfolio of products, which includes tablets, hard capsules, lyophilized powder, lyophilized powder injections, small-volume injections, and raw materials. Moreover, the company has marked its global footprint by exporting its products, ensuring its presence in the international market and fulfilling the needs of patients worldwide.
Enzymes: The company has developed a solid reputation for its range of enzyme products, which play a crucial role in various medical treatments.
Polysaccharides Products: Changzhou Qianhong Biopharma also distinguishes itself in the field of polysaccharides, offering a variety of essential drugs.
In addition to these, the company ensures the availability of such essential drugs in injection forms, catering to various medical needs and administration preferences.